Metabolism of boswellic acids in vitro and in vivo

Drug Metabolism and Disposition

Volumn 36, Issue 6, 2008, Pages 1135-1142

  Krüger, Phillip ^a   Daneshfar, Rambod ^c   Eckert, Gunter P ^b   Klein, Jochen ^b   Volmer, Dietrich A ^d   Bahr, Ute ^b   Müller, Walter E ^b   Karas, Michael ^b   Schubert Zsilavecz, Manfred ^a,b   Abdel Tawab, Mona ^a  

^a ABDA Bundesvereinigung Deutscher Apothekerverbande   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^d MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11 KETO BETA BOSWELLIC ACID; 3 ACETYL 11 KETO BETA BOSWELLIC ACID; BOSWELLIC ACID;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DEACETYLATION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG METABOLISM; FEMALE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY DISEASE; LIVER CELL; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BRAIN; CELLS, CULTURED; FEMALE; HEPATOCYTES; HUMANS; LIVER; MALE; MICROSOMES, LIVER; RATS; RATS, WISTAR; TRITERPENES;

BOSWELLIA SERRATA; RATTUS;

EID: 44149095046     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.107.018424     Document Type: Article

References (22)

1. Abdel Tawab M, Kaunzinger A, Bahr U, Karas M, Wurglics M, and Schubert-Zsilavecz M (2001) Development of a high-performance liquid chromatographic method for the determination of 11-keto-β-boswellic acid in human plasma. J Chromatogr Biomed Appl 761:221-227.
2. Berry MN and Friend DS (1969) High yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol 43:506-520.
3. Büchele B and Simmet T (2003) Analysis of 12 different pentacyclic triterpenic acids from frankincense in human plasma by high-performance liquid chromatography and photodiode array detection. J Chromatogr B Analyt Technol Biomed Life Sci 795:355-362.
4. Culioli G, Mathe C, Archier P, and Vieillescazes C (2003) A lupane triterpene from frankincense (Boswellia sp., Burseraceae). Phytochemistry 62:537-541.
5. Frank A and Unger M (2006) Analysis of frankincense from various Boswellia species with inhibitory activity on human drug metabolising cytochrome P450 enzymes using liquid chromatography mass spectrometry after automated on-line extraction. J Chromatogr A 1112:255-262.
6. Gerhardt H, Seifert F, Buvari P, Vogelsang H, and Repges RZ (2001) Therapy of active Crohn disease with Boswellia serrata extract H 15. Gastroenterology 39:11-17.
7. Gupta I, Parihar A, Malhotra P, Singh GB, Luedtke R, Safayhi H, and Ammon HPT (1997) Effects of Boswellia serrata gum resin in patients with ulcerative colitis. Eur J Med Res 2:37-43.
8. Gupta I, Gupta V, Parihar A, Gupta S, Ludtke R, Safayhi H, and Ammon HPT (1998) Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study. Eur J Med Res 3:511-514.
9. Gupta I, Parihar A, Malhotra P, Gupta S, Ludtke R, Safayhi H, and Ammon HPT (2001) Effects of gum resin of Boswellia serrata in patients with chronic colitis. Planta Med 67:391-395.
10. Jeong DW, Kim YH, Kim HH, Ji HY, Yoo SD, Choi WR, Lee SM, Han CK, and Lee HS (2007) Dose-linear pharmacokinetics of oleanolic acid after intravenous and oral administration in rats. Biopharm Drug Dispos 28:51-57.
11. Poeckel D and Werz O (2006) Boswellic acids: biological actions and molecular targets. Curr Med Chem 13:3359-3369.
12. Reising K, Meins J, Bastian B, Eckert G, Mueller WE, Schubert-Zsilavecz M, and Abdel Tawab M (2005) Determination of boswellic acids in brain and plasma by high-performance liquid chromatography/tandem mass spectrometry. Anal Chem 77:6640-6645.
13. Safayhi H, Mack T, Sabieraj J, Anazodo M, Subramanian LR, and Ammon HPT (1992) Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase. J Pharmacol Exp Ther 261:1143-1146.
14. Safayhi H, Rall B, Sailer ER, and Ammon HPT (1997) Inhibition by boswellic acids of human leukocyte elastase. J Pharmacol Exp Ther 281:460-463.
15. Sailer ER, Subramanian LR, Rall B, Hoernlein RF, Ammon HPT, and Safayhi H (1996) Acetyl-11-keto-β-boswellic acid (AKBA): structure requirements for binding and 5-lipoxygenase inhibitory activity. Br J Pharmacol 117:615-618.
16. Sander O, Herborn G, and Rau R (1998) Is H15 (resin extract of Boswellia serrata, "incense") a useful supplement to established drug therapy of chronic polyarthritis? Results of a double-blind pilot study. Z Rheumatol 57:11-16.
17. Sharma S, Thawani V, Hingorani L, Shrivastava M, Bhate VR, and Khiyani R (2004) Pharmacokinetic study of 11-keto β-Boswellic acid. Phytomedicine 11:1255-1260.
18. Shearer TW, Smith KS, Diaz D, Asher C, and Ramirez J (2005) The role of in vitro ADME assays in antimalarial drug discovery and development. Comb Chem High Throughput Screen 8:89-98.
19. Sterk V, Büchele B, and Simmet T (2004) Effect of food intake on the bioavailability of boswellic acids from a herbal preparation in healthy volunteers. Planta Med 70:1155-1160.
20. Syrovets T, Büchele B, Krauss C, Laumonnier Y, and Simmet T (2005) Acetyl-boswellic acids inhibit lipopolysaccharide-mediated TNF-α induction in monocytes by direct interaction with IκB kinases. J Immunol 174:498-506.
21. Weber CC, Reising K, Müller WE, Schubert-Zsilavecz M, and Abdel Tawab M (2006) Modulation of Pgp function by boswellic acids. Planta Med 72:507-513.
22. Winking M, Sarikaya S, Rahmanian A, Jodicke A, and Boker DK (2000) Boswellic acids inhibit glioma growth: a new treatment option? J Neurooncol 46:97-103.